BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6400065)

  • 1. Induction of leukemia cell differentiation by chemotherapeutic agents.
    Schwartz EL; Ishiguro K; Sartorelli AC
    Adv Enzyme Regul; 1983; 21():3-20. PubMed ID: 6400065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
    Schwartz EL; Sartorelli AC
    Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.
    Sartorelli AC
    Br J Cancer; 1985 Sep; 52(3):293-302. PubMed ID: 3899154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin.
    Steinheider G; Westendorf J; Marquardt H
    Leuk Res; 1986; 10(10):1233-9. PubMed ID: 3464812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.
    Ishiguro K; Schwartz EL; Sartorelli AC
    J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
    Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
    Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
    Schwartz EL; Blair OC; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of human promyelocytic leukemia cells in vitro by 6-thioguanine.
    Papac RJ; Brown AE; Schwartz EL; Sartorelli AC
    Cancer Lett; 1980 Jul; 10(1):33-8. PubMed ID: 6939481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of differentiation-inducer-resistant HL-60 cells.
    Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
    Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.
    Steinheider G; Schaefer A; Westendorf J; Marquardt H
    Cell Biol Toxicol; 1988 Mar; 4(1):123-33. PubMed ID: 3228706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanine analog-induced differentiation of human promyelocytic leukemia cells and changes in queuine modification of tRNA.
    Kretz KA; Katze JR; Trewyn RW
    Mol Cell Biol; 1987 Oct; 7(10):3613-9. PubMed ID: 3479681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
    Morin MJ; Sartorelli AC
    Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
    Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
    Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells.
    Collins SJ; Bodner A; Ting R; Gallo RC
    Int J Cancer; 1980 Feb; 25(2):213-8. PubMed ID: 6156128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-ethylmercaptopurine-mediated growth inhibition of HL-60 cells in vitro irrespective of purine salvage.
    Gibboney DS; French BT; Patrick DE; Trewyn RW
    Cancer Chemother Pharmacol; 1989; 25(3):189-94. PubMed ID: 2598410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
    Zimm S; Johnson GE; Poplack DG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in the induction of malignant cell differentiation.
    Sartorelli AC; Ishiguro K; King CL; Morin MJ; Reiss M
    Adv Enzyme Regul; 1986; 25():507-29. PubMed ID: 3544708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of erythroid differentiation in vitro by purines and purine analogues.
    Gusella JF; Housman D
    Cell; 1976 Jun; 8(2):263-9. PubMed ID: 971485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.